UCB Group (UCBJF.PK) Plans Job Cuts
11/17/2009 8:37:06 AM
More...
|
UCB Group (UCBJF.PK) Raises 450 Million Euros from Convertible Bonds
10/1/2009 7:10:07 AM
More...
|
UCB Group (UCBJF.PK) and Biogen Idec, Inc. (Massachusetts) (BIIB) Discontinue Phase II Clinical Trial of CDP323
7/1/2009 7:55:05 AM
More...
|
EU Lifts Restrictions on UCB Group (UCBJF.PK)'s Neupro
6/29/2009 7:58:27 AM
More...
|
UCB Group (UCBJF.PK) Arthritis Drug Cimzia Wins EU Watchdog Approval
6/26/2009 7:11:23 AM
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) And UCB Group (UCBJF.PK) Announce Second Phase III Study Of Sodium Oxybate In Patients With Fibromyalgia Meets Primary Endpoints
6/25/2009 10:03:26 AM
More...
|
UCB Group (UCBJF.PK)'s Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease
5/18/2009 8:23:42 AM
More...
|
XOMA (US) LLC (XOMA) Royalties On CIMZIA(r) Expected to Increase Due to FDA Approval for Moderate to Severe Rheumatoid Arthritis in Adults
5/15/2009 10:04:32 AM
More...
|
UCB Group (UCBJF.PK) Soars as U.S. Clears Key Arthritis Drug
5/14/2009 7:22:23 AM
More...
|
UCB Group (UCBJF.PK) Release: New Keppra XR(TM) Dosage Strength Offers Simplified Treatment Option for People Living With Partial-Onset Seizures
4/10/2009 8:15:31 AM
More...
|
|